Vimarsana
Biggest News Aggregation in the World

Page 2 - Nasdaq Scph News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Scph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Scph Today - Breaking & Trending Today

Cowen AND Company LLC Invests $25.47 Million in scPharmaceuticals Inc. (NASDAQ:SCPH) - Vimarsana News

Cowen AND Company LLC Invests $25.47 Million in scPharmaceuticals Inc. (NASDAQ:SCPH)

Cowen AND Company LLC acquired a new position in scPharmaceuticals Inc. (NASDAQ:SCPH – Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 2,807,562 shares of the company’s stock, valued at approximately $25,465,000. scPharmaceuticals accounts for 3.0% of Cowen AND […]

scPharmaceuticals Inc. (NASDAQ:SCPH) Given Consensus Rating of "Buy" by Brokerages - Vimarsana News

scPharmaceuticals Inc. (NASDAQ:SCPH) Given Consensus Rating of "Buy" by Brokerages

Shares of scPharmaceuticals Inc. (NASDAQ:SCPH – Get Free Report) have been assigned an average rating of “Buy” from the six analysts that are currently covering the stock, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have issued ratings on the […]

scPharmaceuticals Inc. (NASDAQ:SCPH) Receives $19.17 Average PT from Analysts - Vimarsana News

scPharmaceuticals Inc. (NASDAQ:SCPH) Receives $19.17 Average PT from Analysts

Shares of scPharmaceuticals Inc. (NASDAQ:SCPH – Get Rating) have been assigned a consensus rating of “Buy” from the six brokerages that are presently covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average twelve-month target price among brokers that have issued ratings on the stock in the last […]

Analysts Set scPharmaceuticals Inc. (NASDAQ:SCPH) Price Target at $19.17 - Vimarsana News

Analysts Set scPharmaceuticals Inc. (NASDAQ:SCPH) Price Target at $19.17

ScPharmaceuticals Inc. (NASDAQ:SCPH – Get Rating) has earned a consensus recommendation of “Buy” from the six brokerages that are covering the company, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy recommendation. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year […]

scPharmaceuticals Inc. (NASDAQ:SCPH) Given Average Rating of "Buy" by Brokerages - Vimarsana News

scPharmaceuticals Inc. (NASDAQ:SCPH) Given Average Rating of "Buy" by Brokerages

ScPharmaceuticals Inc. (NASDAQ:SCPH – Get Rating) has received an average recommendation of “Buy” from the six analysts that are covering the stock, MarketBeat.com reports. Five research analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have covered the stock in the last year is $19.17. A number […]